Andrea Biondi

Research interests

Publications

• The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

  Proceedings of the National Academy of Sciences · 2022 · https://doi.org/10.1073/pnas.2200413119

• X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

  Science Immunology · 2021 · https://doi.org/10.1126/sciimmunol.abl4348

• Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

  Science Immunology · 2021 · https://doi.org/10.1126/sciimmunol.abl4340

• Autoantibodies against type I IFNs in patients with life-threatening COVID-19

  Science · 2020 · https://doi.org/10.1126/science.abd4585

• Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

  Science · 2020 · https://doi.org/10.1126/science.abd4570

• Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

  Journal of Clinical Oncology · 2019 · https://doi.org/10.1200/jco.19.00261

• Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.59.1636

• An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia

  Cancer Cell · 2012 · https://doi.org/10.1016/j.ccr.2012.10.007

• Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

  The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)61341-0

• A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

  The Lancet · 2007 · https://doi.org/10.1016/s0140-6736(07)61126-x

• The MLL recombinome of acute leukemias

  Leukemia · 2006 · https://doi.org/10.1038/sj.leu.2404150

• Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

  Leukemia · 2006 · https://doi.org/10.1038/sj.leu.2404149

• Biological and therapeutic aspects of infant leukemia

  Blood · 2000 · https://doi.org/10.1182/blood.v96.1.24

• Therapy of Molecular Relapse in Acute Promyelocytic Leukemia

  Blood · 1999 · https://doi.org/10.1182/blood.v94.7.2225.419k03_2225_2229

• Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

  Leukemia · 1999 · 10.1038/sj.leu.2401592

• Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

  PubMed · 1997 · https://doi.org/10.1182/blood.v89.10.3534

• Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

  PubMed · 1997 · https://doi.org/10.1182/blood.v90.3.1014

Current projects

No projects listed.